# Subcostal TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Donor Nephrectomy Patients: A Prospective Study

> **NCT02287623** · PHASE4 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 60 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** liposomal bupivacaine
- **DRUG:** bupivacaine

## Key facts

- **NCT ID:** NCT02287623
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-07
- **Final completion:** 2014-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02287623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02287623, "Subcostal TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Donor Nephrectomy Patients: A Prospective Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02287623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*